Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking
Timothy M. Block(Hepatitis B Foundation), Raymond A. Dwek(University of Oxford), Baruch S. Blumberg(Université Claude Bernard Lyon 1), Mathew Ebling(Sidney Kimmel Cancer Center), Bud C. Tennant(Fox Chase Cancer Center), David M. Lansky(Monsanto (United States)), Xuanyong Lu(Sidney Kimmel Cancer Center), Anand S. Mehta(Drexel University), Gary S. Jacob(Monsanto (United States)), Brent Korba(Georgetown University)
Cited by 152
Related Papers
A "New" Antigen in Leukemia Sera
|JAMA|1965|1.3k
A Serum Antigen (Australia Antigen) in Down's Syndrome, Leukemia, and Hepatitis
|Annals of Internal Medicine|1967|652
Particles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and Hepatitis
|Nature|1968|423
Comparison of the methods for profiling glycoprotein glycans—HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study
|Glycobiology|2007|396
The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives
|Proceedings of the National Academy of Sciences|2003|377